Skip to main content

and
  1. Article

    Optimal treatment strategy after first-line induction therapy in advanced HER2-positive oeso-gastric adenocarcinoma—a retrospective, international, multicentric AGEO study

    The optimal treatment strategy after first-line induction therapy in advanced HER2-positive oeso-gastric adenocarcinoma (OGA) remains challenging.

    Elisabeth S. Bergen, Lorenzo Pilla, Edouard Auclin, Aysegül Ilhan-Mutlu in Gastric Cancer (2023)